Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis

Hareth Al‐Janabi; Job van Exel; Werner Brouwer; Caroline Trotter; Linda Glennie; Laurie Hannigan; Joanna Coast

doi:10.1002/hec.3259

journal article Open Access Oct 14, 2015

Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis

Hareth Al‐Janabi Job van Exel

Werner Brouwer

Caroline Trotter Linda Glennie Laurie Hannigan Joanna Coast

Health Economics Vol. 25 No. 12 pp. 1529-1544 · Wiley

View at Publisher Save 10.1002/hec.3259

Abstract

SummaryThe health of carers and others close to the patient will often be relevant to economic evaluation, but it is very rarely considered in practice. This may reflect a lack of understanding of how the spillover effect of illness can be appropriately quantified. In this study we used three different approaches to quantify health spillovers resulting from meningitis. We conducted a survey of 1218 family networks affected by meningitis and used regression modelling to estimate spillover effects. The findings show that meningitis had long‐term effects on family members' health, particularly affecting the likelihood of family members reporting anxiety and depression. These effects extended beyond a single close family member. These findings suggest that vaccinating against meningitis will bring significant health benefits not just to those that might have contracted the illness but also to their family networks. In methodological terms, different approaches for quantifying health spillovers provided broadly consistent results. The choice of method will be influenced by the ease of collecting primary data from family members in intervention contexts. © 2015 The Authors.Health Economicspublished by John Wiley & Sons Ltd.

Topics

No keywords indexed for this article. Browse by subject →

References

48

[1]

10.2165/11593940-000000000-00000

[2]

10.1093/fampra/cmh418

[3]

10.1177/0272989x09349959

[4]

10.1016/j.jhealeco.2004.12.002

[5]

10.1177/0272989x08324955

[6]

10.1016/j.jhealeco.2010.05.003

[7]

Health Effects in Significant Others

Ana Bobinac, N. Job A. van Exel, Frans F. H. Rutten et al.

Medical Decision Making 10.1177/0272989x10374212

[8]

10.1016/j.jhealeco.2007.07.003

[9]

10.1017/s0266462399152346

[10]

10.1002/art.20528

[11]

10.1002/sim.5408

[12]

10.1016/s0277-9536(02)00370-2

[13]

Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study

H. Christensen, C. L. Trotter, M. Hickman et al.

BMJ 10.1136/bmj.g5725

[14]

ClaxtonK WalkerS PalmerS SculpherM.2010.Appropriate perspectives for healthcare decisions. CHE Research paper no. 54. University of York.

[15]

10.1016/j.socscimed.2008.06.027

[16]

10.1002/hec.1512

[17]

10.1093/oxfordjournals.oep.a041190

[18]

10.1093/oxrep/5.1.34

[19]

10.1111/j.1475-4932.1980.tb01672.x

[20]

10.1007/s10198-007-0076-z

[21]

10.1017/s0266462300005109

[22]

Drummond M (2005) 10.1093/oso/9780198529446.001.0001

[23]

Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis

Karen Edmond, Andrew Clark, Viola S Korczak et al.

The Lancet Infectious Diseases 10.1016/s1473-3099(10)70048-7

[24]

10.1016/0277-9536(95)00296-0

[25]

Gold M (1996) 10.1093/oso/9780195108248.001.0001

[26]

The Inclusion of Informal Care in Applied Economic Evaluation: A Review

Kacey Goodrich, Billingsley Kaambwa, Hareth Al-Janabi

Value in Health 10.1016/j.jval.2012.05.009

[27]

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

M. Herdman, C. Gudex, A. Lloyd et al.

Quality of Life Research 10.1007/s11136-011-9903-x

[28]

10.1016/j.jhealeco.2013.03.005

[29]

10.1016/j.healthpol.2004.11.008

[30]

10.1007/s40273-014-0218-y

[31]

10.1007/s40258-014-0079-8

[32]

10.1097/mlr.0b013e3181c162a2

[33]

10.1037/a0021020

[34]

Identification of Endogenous Social Effects: The Reflection Problem

Charles F. Manski

The Review of Economic Studies 10.2307/2298123

[35]

NICE (National Institute for Health and Care Excellence).2013.Guide to the methods of technology appraisal.

[36]

10.1016/j.parkreldis.2011.02.009

[37]

10.1037/0882-7974.18.2.250

[38]

10.1007/s11136-011-9991-7

[39]

10.1542/peds.113.2.283

[40]

10.1177/1074840707307917

[41]

10.1007/s11136-004-3305-2

[42]

10.2165/11591570-000000000-00000

[43]

Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

Ben van Hout, M.F. Janssen, You-Shan Feng et al.

Value in Health 10.1016/j.jval.2012.02.008

[44]

10.1016/s1474-4422(12)70180-1

[45]

Visintin C "Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance" British Medical Journal (2010)

[46]

10.1007/s40273-013-0040-y

[47]

10.1177/0272989x12464434

[48]

10.1007/s11136-004-3288-z

Metrics

88

Citations

48

References

Details

Published: Oct 14, 2015
Vol/Issue: 25(12)
Pages: 1529-1544
License: View

Authors

H

Hareth Al‐Janabi

Health Economics Unit, School of Health and Population Sciences University of Birmingham Birmingham UK

J

Job van Exel

Institute of Health Policy and Management Erasmus University Rotterdam Rotterdam Netherlands

W

Werner Brouwer

Institute of Health Policy and Management Erasmus University Rotterdam Rotterdam Netherlands

C

Caroline Trotter

Disease Dynamics Unit, Department of Veterinary Medicine University of Cambridge Cambridge UK

L

Linda Glennie

Meningitis Research Foundation Bristol UK

L

Laurie Hannigan

Meningitis Research Foundation Bristol UK

J

Joanna Coast

Health Economics Unit, School of Health and Population Sciences University of Birmingham Birmingham UK

Funding

Medical Research Council Award: G1002334

Cite This Article

Hareth Al‐Janabi, Job van Exel, Werner Brouwer, et al. (2015). Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis. Health Economics, 25(12), 1529-1544. https://doi.org/10.1002/hec.3259

Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis

You May Also Like